#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Usher's syndrome Pneumonia Loss of consciousness B precursor type acute leukaemia Dementia Alzheimer's type Pancreatic carcinoma metastatic Gastrointestinal stromal tumour Lennox-Gastaut syndrome Cortical dysplasia Ewing's sarcoma Oesophageal achalasia Ocular myasthenia Chondrosarcoma Congenital pseudarthrosis More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Treatment Rhabdomyosarcoma – Diagnostics Mantle cell lymphoma stage III – Basic Information Anaplastic thyroid cancer – Treatment Hyperoxaluria Glomerulonephritis rapidly progressive – Trials in Disease Uterine leiomyosarcoma – Treatment Hereditary optic atrophy – Life with Disease Phenylketonuria – Basic Information Haemophagocytic lymphohistiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Edotreotide Platelet Concentrate Melphalan Sulodexide SOFTISAN 378 Tigecycline Marstacimab Ecoo4 Carboplatin Tegafur Alxn1850 LTI-03 ZILUCOPLAN Cyclophosphamide Ecopipam Hydrochloride Phosphocreatine Sodium Itacitinib Hypromellose Albiglutide MB-001 More therapies…

    Learn about Your Condition

    Myositis Meningorrhagia Breast angiosarcoma Rhabdoid tumour of the kidney Colorectal cancer Gaucher's disease type III Open angle glaucoma Piriformis syndrome Neurogenic bladder Aplasia pure red cell Haemorrhoids Renal injury Polymyalgia rheumatica Compulsive sexual behaviour Craniopharyngioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Masitinib
    Denmark France Greece Norway Sweden

  • Study on Filgotinib and Triamcinolone for Newly Diagnosed Rheumatoid Arthritis Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Filgotinib
    • Triamcinolone Acetonide
    The Netherlands

  • Study of Pembrolizumab and Enfortumab Vedotin for Patients with Collecting Duct and Renal Medullary Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-renal cell carcinoma of kidney
    • Renal cell carcinoma
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on Avelumab for Patients with Advanced Urothelial Cancer After Initial Chemotherapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Avelumab
    The Netherlands

  • Study on Magnesium Sulfate for Reducing Postoperative Pain in Women After Cesarean Section

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Magnesium Sulfate
    Sweden

  • Study on the Safety and Effectiveness of Nivolumab and Ipilimumab for Patients with Metastatic Colorectal Cancer with dMMR or MSI

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France
Previous Page
1 … 822 823 824 825 826 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!